United-Guardian, Inc. (UG) |
| 7.01 -0.01 (-0.14%) 06-12 16:00 |
| Open: | 7 |
| High: | 7.05 |
| Low: | 7 |
| Volume: | 2,687 |
| Market Cap: | 32(M) |
| PE Ratio: | 13.48 |
| Exchange: | NASDAQ Global Market |
| Industry: | Household & Personal Products |
| Sector: | Consumer Defensive |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 7.49 |
| Resistance 1: | 7.21 |
| Pivot price: | 7.00 |
| Support 1: | 6.75 |
| Support 2: | 5.62 |
| 52w High: | 9.88 |
| 52w Low: | 5.58 |
United-Guardian, Inc., operating both domestically and globally, specializes in the development, production, and distribution of a diverse range of cosmetic raw materials, pharmaceutical solutions, medical-grade lubricants, and proprietary industrial chemicals. Its extensive cosmetic ingredients catalog includes the LUBRAJEL line of water-based moisturizing and lubricating gel formulations, featuring variants such as LUBRAJEL NATURAL (derived from natural sources), LUBRAJEL MARINE, and LUBRASIL II SB (a silicone-infused LUBRAJEL formulation). Other key offerings in this category are LUBRAJEL II XD; B-122, a powdered lubricant suitable for pressed powders, eyeliners, blushes, and industrial uses; KLENSOFT, a surfactant for shampoos, shower gels, and makeup removers; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, and cleansers. For medical applications, United-Guardian provides lubricants like LUBRAJEL RR and RC, which are water-based gels specifically designed for urinary catheters. LUBRAJEL MG serves to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices. The company also offers LUBRAJEL LC and LUBRAJEL FA, specialized LUBRAJEL formulations tailored for oral care, alongside LUBRAJEL FLUID for lubricating various water-soluble products. The pharmaceutical portfolio features RENACIDIN, a prescription medication for preventing and dissolving calcifications in urethral catheters and the urinary bladder. Also included is CLORPACTIN WCS-90, an antimicrobial agent effective against infections in the urinary bladder, localized peritoneal infections, and infections affecting the eyes, ears, nose, throat, and sinuses. Industrial products comprise DESELEX, a sequestering and chelating agent vital for detergent manufacturing, and THOROCLENS, a powerful chlorine-based industrial cleaning solution. The firm also dedicates resources to research and development, primarily focusing on advancing cosmetic ingredients. Products are brought to market through a robust network of marketing partners, distributors, and wholesalers. Established in 1942, United-Guardian maintains its headquarters in Hauppauge, New York.
| EPS | 0.520 |
| Book Value | 2.440 |
| PEG Ratio | 1.12 |
| Gross Profit | 1.135 |
| Profit Margin (%) | 21.61 |
| Operating Margin (%) | 22.37 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Sun, 07 Jun 2026
Precision Trading with United-guardian Inc. (UG) Risk Zones - Stock Traders Daily
Fri, 05 Jun 2026
UG News | UNITED GUARDIAN INC (NASDAQ:UG) - ChartMill
Mon, 18 May 2026
United-Guardian Q1 Earnings Rise Y/Y on Strong Renacidin Demand - Yahoo Finance
Tue, 12 May 2026
United Guardian Inc 1Q 2026: Revenue $2.87M, EPS $0.18— 10-Q Summary - TradingView
Fri, 08 May 2026
Renacidin demand, Ashland orders lift United-Guardian Q1 profit - Stock Titan
Fri, 08 May 2026
United-Guardian, Inc. Reports First Quarter 2026 Sales and Net Income Increase - Quiver Quantitative
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |